ResearcherDalian Medical UniversityActive in the last 2 years
Guixin Zhang
Matched on ORCID iD 0000-0002-6171-394X; OpenAlex author ID A5100627958. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 5
- Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-026-04625-x↗
- Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer: a systematic revie… Last author DOI 10.3389/fonc.2025.1510342↗
- A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2023.09.050↗
- Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Co-author DOI 10.3389/fonc.2021.667427↗
- The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jare.2020.03.009↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Caiming Xu · 4 shared papers, 2020–2025 · strength 0.72
- Paper Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sid… DOI 10.3389/fonc.2025.1510342↗
- Paper A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2023.09.050↗
- Paper Application of Mass Spectrometry in Pancreatic Cancer Translational Research. DOI 10.3389/fonc.2021.667427↗
- John S. Bolton · 2 shared papers, 2024–2026 · strength 0.39
- Eunsung Jun · 2 shared papers, 2024–2026 · strength 0.39
- Erkut Hasan Borazanci · 2 shared papers, 2024–2026 · strength 0.39
- Ajay Goel · 2 shared papers, 2024–2026 · strength 0.39
- Song Cheol Kim · 2 shared papers, 2024–2026 · strength 0.39
- Daniel D. Von Hoff · 2 shared papers, 2024–2026 · strength 0.39
- Xutao Jiang · 1 shared paper, 2025 · strength 0.28
- Wei Li · 1 shared paper, 2025 · strength 0.28
- Hailong Chen · 2 shared papers, 2020–2021 · strength 0.24
- Caiming Xu · 1 shared paper, 2026 · strength 0.20
- Mitsuro Kanda · 1 shared paper, 2026 · strength 0.20
- Derek Cridebring · 1 shared paper, 2026 · strength 0.20
- Laleh Golkar Melstrom · 1 shared paper, 2026 · strength 0.20
- Scott A. Celinski · 1 shared paper, 2026 · strength 0.20
- Giulia Martina Cavestro · 1 shared paper, 2026 · strength 0.20
- Carlos Roberto Becerra · 1 shared paper, 2026 · strength 0.20
- Douglas B. Evans · 1 shared paper, 2026 · strength 0.20
- Haiyong Han · 1 shared paper, 2026 · strength 0.20
- David L. Bartlett · 1 shared paper, 2026 · strength 0.20
- Vincent M. Chung · 1 shared paper, 2026 · strength 0.20
- Alessandro Mannucci · 1 shared paper, 2026 · strength 0.20
- Joon Oh Park · 1 shared paper, 2026 · strength 0.20
- Dong Shang · 1 shared paper, 2026 · strength 0.20
- Mustafa Raoof · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.